A detailed history of Aqr Capital Management LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 149,562 shares of EOLS stock, worth $2.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
149,562
Previous 72,007 107.7%
Holding current value
$2.13 Million
Previous $781,000 210.12%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.66 - $17.48 $826,736 - $1.36 Million
77,555 Added 107.7%
149,562 $2.42 Million
Q2 2024

Aug 14, 2024

BUY
$10.45 - $13.76 $187,796 - $247,280
17,971 Added 33.26%
72,007 $781,000
Q1 2024

May 15, 2024

BUY
$9.99 - $14.91 $38,791 - $57,895
3,883 Added 7.74%
54,036 $756,000
Q4 2023

Feb 14, 2024

SELL
$7.6 - $10.53 $19,668 - $27,251
-2,588 Reduced 4.91%
50,153 $528,000
Q3 2023

Nov 14, 2023

SELL
$7.15 - $10.2 $1,415 - $2,019
-198 Reduced 0.37%
52,741 $482,000
Q2 2023

Aug 14, 2023

BUY
$7.23 - $10.52 $115,325 - $167,804
15,951 Added 43.12%
52,939 $384,000
Q1 2023

May 15, 2023

SELL
$7.81 - $11.05 $514,960 - $728,592
-65,936 Reduced 64.06%
36,988 $312,000
Q4 2022

Feb 14, 2023

SELL
$6.52 - $8.95 $38,187 - $52,420
-5,857 Reduced 5.38%
102,924 $772,000
Q3 2022

Nov 14, 2022

BUY
$7.76 - $13.72 $766,525 - $1.36 Million
98,779 Added 987.59%
108,781 $876,000
Q2 2022

Aug 15, 2022

SELL
$10.22 - $13.94 $21,901 - $29,873
-2,143 Reduced 17.65%
10,002 $116,000
Q1 2022

May 16, 2022

SELL
$5.22 - $11.78 $603,473 - $1.36 Million
-115,608 Reduced 90.49%
12,145 $136,000
Q4 2021

Feb 14, 2022

BUY
$5.37 - $8.38 $64,735 - $101,020
12,055 Added 10.42%
127,753 $832,000
Q3 2021

Nov 15, 2021

BUY
$7.36 - $13.67 $232,664 - $432,136
31,612 Added 37.59%
115,698 $882,000
Q2 2021

Aug 16, 2021

BUY
$8.42 - $13.96 $708,004 - $1.17 Million
84,086 New
84,086 $1.06 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $797M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.